Top Institutions in Ophthalmology - Retina
Leading institutions have pioneered clinical trials and translational research on complement inhibitors for GA, combining advanced retinal imaging techniques with long-term patient monitoring to optimize treatment timing and outcomes.
-
#1
Massachusetts Eye and Ear Infirmary
Boston, MA
Massachusetts Eye and Ear is a global leader in retinal disease research, including pioneering clinical trials on complement inhibition therapies for geographic atrophy and advanced retinal imaging modalities.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Trials
-
#2
Bascom Palmer Eye Institute, University of Miami
Miami, FL
Bascom Palmer is renowned for its clinical and translational research in AMD and GA, with expertise in intravitreal therapies and patient management strategies for retinal degenerations.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Research
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute has a robust research portfolio in AMD pathophysiology and novel therapeutics, including complement pathway modulation and advanced imaging techniques for GA.
Key Differentiators
- Ophthalmology
- Retina
- Vision Science
-
#4
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF has contributed significantly to clinical trials of complement inhibitors and has expertise in managing complex retinal degenerations with cutting-edge imaging and therapeutic approaches.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Trials
-
#5
Moorfields Eye Hospital
London, N/A
Moorfields is a leading international center for retinal disease research, with extensive clinical trial experience and expertise in imaging and managing geographic atrophy.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Research
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







